Evidence map›Paper›PMID 36142000›Full record

ReviewInternational journal of environmental research and public health2022

Challenges and Suggestions in Management of Lung and Liver Cancer in Uzbekistan: The Second Report of the Uzbekistan-Korea Oncology Consortium.

Chai Hong Rim, Won Jae Lee, Bekhzood Musaev, Ten Yakov Volichevich, Ziyayev Yakhyo Pazlitdinovich, Tillysshaykhov Mirzagaleb Nigmatovich, Jae Suk Rim, Consortium of Republican Specialized Scientific Practical-Medical Center of Oncology and Radiology and South Korean Oncology Advisory Group

Abstract readReview
In one paragraph

Review in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chai Hong RimDepartment of Radiation Oncology, Korea University Ansan Hospital, Korea University, Seoul 02841, Korea.ORCID 0000-0001-7431-4588
Won Jae LeeDepartment of Healthcare Management, Gachon University, Seongnam 13120, Korea.
Bekhzood MusaevMinistry of Health of the Republic of Uzbekistan, Tashkent 100086, Uzbekistan.
Ten Yakov VolichevichRepublican Specialized Scientific Practical-Medical Center of Oncology and Radiology, Farobiy Street 383, Tashkent 100179, Uzbekistan.ORCID 0000-0002-9970-1936
Ziyayev Yakhyo PazlitdinovichRepublican Specialized Scientific Practical-Medical Center of Oncology and Radiology, Farobiy Street 383, Tashkent 100179, Uzbekistan.
Tillysshaykhov Mirzagaleb NigmatovichRepublican Specialized Scientific Practical-Medical Center of Oncology and Radiology, Farobiy Street 383, Tashkent 100179, Uzbekistan.
Jae Suk RimDepartment of Oral & Maxillofacial Surgery, Guro Hospital, Korea University College of Medicine, 148 Gurodong-ro, Guro 2-dong, Guro-gu, Seoul 08308, Korea.
Consortium of Republican Specialized Scientific Practical-Medical Center of Oncology and Radiology and South Korean Oncology Advisory Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The health burden of cancer increases in Uzbekistan as the country develops and the life expectancy increases. Management of such a burden requires efficient screening, treatment optimization, and investigation of the causes of cancer. The Ministry of Health of Uzbekistan formed an advisory consortium, including clinical oncology and healthcare management experts from Uzbekistan and South Korea, to design a strategy for cancer management. Our consortium has analyzed six cancer types with high morbidity and mortality in Uzbekistan by classifying them into three categories (breast, cervical (gynecologic cancers), lung, liver (cancer common in men), stomach, and colorectal cancers (gastrointestinal cancers)). Lung and liver cancers are common causes of death in men after middle age-they can yield a serious health burden on the country and ruin the livelihood of families. In this review, we will analyze the oncologic literature and suggest practical recommendations for the treatment and prevention of lung and liver cancer in Uzbekistan. Data from South Korea, which has conducted nationwide screening for two decades and made progress in improving prognosis, will be discussed as a comparative control.

Indexed as

Liver NeoplasmsNeoplasmsFemaleHumansLungMaleMedical OncologyMiddle AgedRepublic of KoreaUzbekistanhepatocellular carcinomaliver cancerlung cancerSouth KoreaUzbekistan

Identifiers

PMID36142000
PMCPMC9517504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.